XML 58 R48.htm IDEA: XBRL DOCUMENT
v3.24.3

Agreements Related to Intellectual Property (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 9 Months Ended |
--- | --- | --- | --- | ---
Jul. 31, 2024 | Oct. 31, 2019 | Aug. 31, 2017 | Sep. 30, 2024 | Sep. 30, 2023 | Sep. 30, 2024 | Sep. 30, 2023 | Dec. 31, 2023
Agreements Related to Intellectual Property |  |  |  |  |  |  |  |
Revenue |  |  |  | $ 4,346 | $ 9,282 | $ 9,509 | $ 13,679 |
Non-cash royalty income |  |  |  | 894 |  | 894 |  |
Contingent consideration |  |  |  | 10,000 |  | 10,000 |  | $ 6,200
License and Service |  |  |  |  |  |  |  |
Agreements Related to Intellectual Property |  |  |  |  |  |  |  |
Revenue |  |  |  | 3,701 | 8,577 | 7,583 | 11,210 |
License Agreement | Sun Pharmaceutical Industries, Inc |  |  |  |  |  |  |  |
Agreements Related to Intellectual Property |  |  |  |  |  |  |  |
Upfront payment receivable |  |  |  |  |  |  |  | $ 15,000
License Agreement | Sun Pharmaceutical Industries, Inc | License and Service |  |  |  |  |  |  |  |
Agreements Related to Intellectual Property |  |  |  |  |  |  |  |
Revenue |  |  |  | 3,000 |  | 3,000 |  |
Non-Exclusive Patent License Agreement | Eli Lilly and Company | OMERS |  |  |  |  |  |  |  |
Agreements Related to Intellectual Property |  |  |  |  |  |  |  |
Percentage of Remaining Anniversary Milestone Payments Payable Acquired | 100.00% |  |  |  |  |  |  |
Non-Exclusive Patent License Agreement | Eli Lilly and Company | License and Service |  |  |  |  |  |  |  |
Agreements Related to Intellectual Property |  |  |  |  |  |  |  |
Revenue |  |  |  | 700 | $ 8,300 | 4,600 | $ 10,700 |
Asset Purchase Agreement |  |  |  |  |  |  |  |
Agreements Related to Intellectual Property |  |  |  |  |  |  |  |
Percentage of Sale of EPI Health Cream |  | 1.00% |  |  |  |  |  |
Agreement and Plan of Merger - Confluence |  |  |  |  |  |  |  |
Agreements Related to Intellectual Property |  |  |  |  |  |  |  |
Additional contingent consideration based on milestones, maximum, per Agreement |  |  | $ 75,000 |  |  |  |  |
Term of agreement |  |  | 10 years |  |  |  |  |
Royalty purchase agreement | OMERS |  |  |  |  |  |  |  |
Agreements Related to Intellectual Property |  |  |  |  |  |  |  |
Non-cash royalty income |  |  |  | $ 900 |  | $ 900 |  |
Proceeds From Upfront Payment | $ 26,500 |  |  |  |  |  |  |
Additional Amount Receivable On Achievement of Sales Milestones | $ 5,000 |  |  |  |  |  |  |

X
- Definition Amount of receivable from additional payments based on the achievement of certain sales milestones pursuant to the agreement. + References No definition available. + Details
Name: | acrs_AdditionalAmountReceivableOnAchievementOfSalesMilestones
Namespace Prefix: | acrs_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The term of agreement. + References No definition available. + Details
Name: | acrs_AgreementTermDuration
Namespace Prefix: | acrs_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The carrying amount as on the date of upfront payment receivable by the Company under the asset purchase agreement. + References No definition available. + Details
Name: | acrs_AssetPurchaseAgreementUpfrontPaymentReceivable
Namespace Prefix: | acrs_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition In a business combination, the maximum contingent consideration to be paid based upon achievement of certain milestones as set forth in the Agreement and Plan of Merger. + References No definition available. + Details
Name: | acrs_BusinessCombinationMaximumContingentConsiderationMilestonePaymentsPerAgreement
Namespace Prefix: | acrs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The percent of remaining anniversary milestone payments payable acquired pursuant to the agreement. + References No definition available. + Details
Name: | acrs_PercentageOfRemainingAnniversaryMilestonePaymentsPayableAcquired
Namespace Prefix: | acrs_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of sale of EPI Health cream. + References No definition available. + Details
Name: | acrs_PercentageOfSaleOfEpiHealthCream
Namespace Prefix: | acrs_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of cash inflow from upfront payment received pursuant to the agreement. + References No definition available. + Details
Name: | acrs_ProceedsFromUpfrontPayment
Namespace Prefix: | acrs_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 35 -Paragraph 1 -Subparagraph b -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_RoyaltyIncomeNonoperating
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=us-gaap_NoncollaborativeArrangementTransactionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=acrs_SunPharmaceuticalIndustriesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=acrs_PatentLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=acrs_EliLillyAndCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=acrs_OntarioMunicipalEmployeesRetirementSystemMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=acrs_AssetPurchaseAgreementEncompassingWorldwideRightsToOxymetazolineHydrochlorideCreamPlusIntellectualPropertyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=acrs_AgreementAndPlanOfMergerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=acrs_RoyaltyPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=acrs_OntarioMunicipalEmployeesRetirementSystemMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |